Skip to main content
. 2022 Aug 3;13:4517. doi: 10.1038/s41467-022-32145-y

Fig. 3. Phylogenetic relationship between baseline and relapse clones.

Fig. 3

We analyzed the phylogenetic relationship between baseline clones from different bone marrow regions and relapse clones to elucidate the origin of resistant disease. To highlight the unknowns in our sample/dataset, we have chosen a format with flipped and unflipped (blank) cards reminiscent of a memory game. In a the mock phylogenetic tree for P6 is shown as an example for a pattern where the unique baseline focal lesion clone and the dominant relapse clone share the phylogenetic branch. The boxes show the proportion of detected subclones, with each subclone having a distinct color. For instance, ten blue dots indicate a proportion of 10% for the “blue” subclone. Dashed lines illustrate the origin/relationship of these subclones and the color code corresponds to the color of the subclones. The gray box/card indicates that tumor data is not available for the respective site at relapse. A timeline of treatment and sampling alongside a detailed mock oncogenetic tree is shown in Suppl. Fig. 8. FU follow-up, VGPR very good partial remission, SD stable disease. b For 12 patients with paired baseline iliac crest/focal lesion samples, the relationship is shown separately for the focal lesion (FL, left bar), and the iliac crest (BM, right bar). No close relationship (gray): baseline and relapse clones represent different evolutionary branches as shown for the dominant iliac crest and the relapse clone in a; selected: a preexisting resistant clone is selected (example in Suppl. Fig. 1); branch: the two clones share the same branch, as shown for the baseline focal lesion and the relapse clone in a; precursor: linear relationship between baseline and relapse clone, i.e., the clone acquires new aberrations; SC subclone is related to relapse clone, MC major/dominant clone is related to relapse clone. Source data are provided as a Source Data file.